914 / 2894
heparin-induced thrombocytopenia. Circulation
103:1838–1843, 2001.
452. Bauer KA: The thrombophilias: Well-defined risk
factors with uncertain therapeutic implications.
Ann Intern Med 135:367–373, 2001.
453. Levine JS, Branch DW, Rauch J: The antiphospholi-
pid syndrome. N Engl J Med 346:752–763, 2002.
454. Evans BE: Dental treatment for hemophiliacs: Eva-
luation of dental program (1975-1976) at the Mount
Sinai Hospital International Hemophilia Training
Center. Mt Sinai J Med 44:409, 1977.
455. Zauber NP, Levin J: Factor IX levels in patients with
hemophilia B (Christmas disease) following trans-
fusion with concentrates of factor IX or fresh
frozen plasma (FFP). Medicine (Baltimore) 56:213,
1977.
456. Brettler DB, Levine PH: Factor concentrates for
treatment of hemophilia: Which one to choose?
Blood 73:2067, 1989.
457. Centers for Disease Control and Prevention (CDC):
Safety of therapeutic products used for hemophilia
patients. MMWR Morb Mortal Wkly Rep
37(29):441, 449-450, 1988.
458. Briere RO: SerumALT levels: Effect of sex, race, and
obesity on unit rejection rate. Transfusion 28:392,
1988.
459. Sloand EM, Pitt E, Klein HG: Safety of the blood
supply. JAMA 274:1368, 1995.
460. Preparation of von Willebrand’s factor. Med Lett
Drugs Ther 35:51, 1993.
461. Lee KF, Manchell J, Rankin JS, et al: Immediate
versus delayed coronary grafting after streptoki-
nase treatment: Postoperative blood loss and clini-
cal results. J Thorac Cardiovasc Surg 95:216,
1988.
462. Dickman CA, Shedd SA, Spetzler RF, et al: Spinal
epidural hematoma associated with epidural anes-
thesia: Complications of systemic heparinization in
patients receiving peripheral vascular thrombolytic
therapy. Anesthesiology 72:947, 1990.
463. Czer LS, Bateman TM, Gary RJ, et al: Treatment of
severe platelet dysfunction and hemorrhage after
cardiopulmonary bypass: Reduction in blood
product usage with desmopressin. J Am Coll
Cardiol 9:1139, 1987.
464. Brigden ML, Barnett JB: A practical approach to
improving pain control in cancer patients. West J
Med 146:580, 1987.
465. Drugs of choice for cancer chemotherapy. Med Lett
Drugs Ther 39:21, 1997.
466. Bishop JM: Molecular themes in oncogenesis. Cell
64:235, 1991.
467. Chung F: Cancer, chemotherapy, and anesthesia.
Can J Anaesth 29:364, 1982.
468. Goldiner P, Carlon GC, Cvitkovic E, et al: Factors
influencing postoperative morbidity and mortality
in patients treated with bleomycin. BMJ 1:1664,
1978.
469. LaMantia KR, Glick JH, Marshall BE: Supplemental
oxygen does not cause respiratory failure in
bleomycin-treated surgical patients.Anesthesiology
60:65, 1984.
470. Matalon S, Harper WV, Nickerson PA, Olszowka J:
Intravenous bleomycin does not alter the toxic
effects of hyperoxia in rabbits. Anesthesiology
64:614, 1986.
471. Roizen MF: Is a patient’s history of food supplement
use simply supplementary? J Clin Anesth 10:89,
1998.
472. How herbal products increase surgical risks.
Nursing Sept:24-25, 2007.
473. Drugs for hypertension.Med Lett Drugs Ther 37:45,
1995.
474. Drugs that cause psychiatric symptoms. Med Lett
Drugs Ther 35:65, 1993.
475. Huyse FJ, Touw DJ, van Schijndel RS, et al: Psycho-
tropic drugs and the perioperative period: A propo-
salforaguidelineinelectivesurgery.Psychosomatics
47:8–22, 2006.
476. The Norwegian Multicenter Study Group: Timolol-
induced reduction in mortality and reinfarction in
patients surviving acute myocardial infarction. N
Engl J Med 304:801, 1981.
477. Frishman WH, Furberg CD, Friedewald WT:
Beta-adrenergic blockade for survivors of acute
myocardial infarction. N Engl J Med 310:830,
1984.
478. Smulyan H,Weinberg SE, Howanitz PJ: Continuous
propranolol infusion following abdominal surgery.
JAMA 247:2539, 1982.
479. Gold MR, Dec GW, Cocca-Spofford DC,Thompson
BT: Esmolol and ventilatory function in cardiac
patients with COPD. Chest 100:1215, 1991.
480. Bloor BC, FlackeWE: Reduction in halothane anes-
thetic requirement by clonidine, an alpha-adrener-
gic agonist. Anesth Analg 61:741, 1982.
481. Weinger MB, Segal IS, Maze M: Dexmedetomidine,
acting through central alpha-2 adrenoceptors, pre-
vents opiate-induced muscle rigidity in the rat.
Anesthesiology 71:242, 1989.
482. Maze M, Tranquilli W: Alpha-2 adrenoreceptor
agonists: Defining the role in clinical anesthesia.
Anesthesiology 74:581, 1991.
483. Segal IS,Jarvis DJ,Duncan SR,et al: Clinical efficacy
of oral-transdermal clonidine combinations during
the perioperative period. Anesthesiology 74:220,
1991.
484. Pandharipande PP, Pon BT, Herr DL, et al: Effect of
sedation with dexmedetanidine vs. lorazepam on
acute brain dysfunction in mechanically ventilated
patients: The MENDS randomized controlled trial.
JAMA 298:2644–2653, 2007.
485. Katz AM: Cardiac ion channels. N Engl J Med
328:1244, 1993.
486. Merin RG, Chelly JE, Hysing ES, et al: Cardiovascu-
lar effects of and interaction between calcium
blocking drugs and anesthetics in chronically ins-
trumented dogs. IV: Chronically administered oral
verapamil and halothane, enflurane, and isoflurane.
Anesthesiology 66:140, 1987.
487. Kapur PA, Matarazzo DA, Fung DM, Sullivan KB:
The cardiovascular and adrenergic actions of vera-
pamil or diltiazem in combination with propranolol
during halothane anesthesia in the dog.Anesthesio-
logy 66:122, 1987.
488. Michaels I, Serrins M, Shier NQ, Barash PG: Anes-
thesia for cardiac surgery in patients receiving
monoamine oxidase inhibitors. Anesth Analg
63:1014, 1984.
489. Evans-Prosser CDG: The use of pethidine and
morphine in the presence of monamine oxidase
inhibitors. Br J Anaesth 40:279, 1968.
490. Roizen MF: Monoamine oxidase inhibitors: Are we
condemned to relive history, or is history no longer
relevant? J Clin Anesth 2:293, 1990.
491. Noble WH, Baker A: MAO inhibitors and coronary
artery surgery: A patient death. Can J Anaesth
39:1061, 1992.
492. Hirshman CA, Linderman KS: Anesthesia and
monoamine oxidase inhibitors. JAMA 261:3407,
1989.
493. El-Ganzouri AR, Ivankovich AD, Braverman B,
McCarthy R: Monoamine oxidase inhibitors:
Should they be discontinued preoperatively?Anesth
Analg 64:592, 1985.
494. Ebrahim ZY,O’Hara JF,Borden L,Tetzlaff J: Monoa-
mine oxidase inhibitors and elective surgery. Cleve
Clin J Med 60:129, 1993.
495. Clarke AG: MAOI’s and anaesthesia. Can J Anaesth
43:641, 1996.
496. Veith RC, Raskind MA, Caldwell JH, et al: Cardio-
vascular effects of tricyclic antidepressants in
depressed patients with chronic heart disease. N
Engl J Med 306:954, 1982.
497. Richelson E, El-Fakahany E: Changes in the sensi-
tivity of receptors for neurotransmitters and the
actions of some psychotherapeutic drugs. Mayo
Clin Proc 57:576, 1982.
498. Katz RL, Bigger JT: Cardiac arrhythmias during
anesthesia and operation. Anesthesiology 33:193,
1970.
499. Horrigan RW, Eger EI II, Wilson CB: Epinephrine-
induced arrhythmias during enflurane anesthesia in
man: A nonlinear dose-response relationship and
dose-dependent protection from lidocaine. Anesth
Analg 57:547, 1978.
500. Marcus ML, Skelton CL, Graver LE, et al: Effects of
theophylline on myocardial mechanics. Am J
Physiol 222:1361, 1972.
501. Westfall DP, Flemming WW: Sensitivity changes
in the dog heart to norepinephrine, calcium and
aminophylline resulting from pretreatment
with reserpine. J Pharmacol Exp Ther 159:98,
1968.
502. Rall TW, West TC: The potentiation of cardiac ino-
tropic responses to norepinephrine by theophylline.
J Pharmacol Exp Ther 139:269, 1963.
503. Drugs: for cardiac arrhythmias. Med Lett Drugs
Ther 38:75, 1996.
504. Harrah MD,Way WL, Katzung BG: The interaction
of
d
-tubocurarine with antiarrhythmic drugs.Anes-
thesiology 33:406, 1970.
505. Telivuo L, Katz RL: The effects of modern intrave-
nous local anesthetics on respiration during partial
neuromuscular block in man. Anaesthesia 25:30,
1970.
506. Miller RD, Way WL, Katzung BG: The potentiation
of neuromuscular blocking agents by quinidine.
Anesthesiology 28:1036, 1967.
507. Pittinger CB, Eryasa Y, Adamson R: Antibiotic-
induced paralysis. Anesth Analg 49:487, 1970.
508. Singh YN, Harvey AL, Marshall IG: Antibiotic-
induced paralysis of the mouse phrenic nerve–
hemidiaphragm preparation, and reversibility by
calcium and by neostigmine.Anesthesiology 48:418,
1978.
509. Pittinger CB, Adamson R: Antibiotic blockade of
neuromuscular function. Annu Rev Pharmacol
12:169, 1972.
510. Becker LD, Miller RD: Clindamycin enhances a
non-depolarizing neuromuscular blockade. Anes-
thesiology 45:84, 1976.
511. Snavely SR, Hodges GR: The neurotoxicity of anti-
bacterial agents. Ann Intern Med 101:92, 1984.
512. McIndewar IC, Marshall RJ: Interactions between
the neuromuscular blocking drug Org NC45 and
some anaesthetic, analgesic and antimicrobial
agents. Br J Anaesth 53:785, 1981.
513. Navalgund AA, Alifimoff JK, Jakymec AJ, Bleyaert
AL: Amiodarone-induced sinus arrest successfully
treated with ephedrine and isoproterenol. Anesth
Analg 65:414, 1986.
514. Kannan R, Nademane K, Hendrickson JA, et al:
Amiodarone kinetics after oral doses. Clin Pharma-
col Ther 31:438, 1982.
515. Rice SA, Sbordone L, Mazzo RI: Metabolism by rat
hepatic microsomes of fluorinated ether anesthetics
following isoniazid administration. Anesthesiology
53:489, 1980.
516. Antimicrobial prophylaxis in surgery. Med Lett
Drugs Ther Guidelines 20:27, 2004.
517. Beller GA,Smith TW,AbelmannWH,et al: Digitalis
intoxication. N Engl J Med 284:989, 1971.
518. Ritchie AJ, Danton M, Gibbons JRP: Prophylactic
digitalisation in pulmonary surgery. Thorax 47:41,
1992.
519. Morrow DH: Anesthesia and digitalis toxicity. VI.
Effect of barbiturates and halothane on digoxin
toxicity. Anesth Analg 49:305, 1970.
520. Pratila MG, Pratilas V: Anesthetic agents and
cardiac electromechanical activity. Anesthesiology
49:338, 1978.
521. Logic JR, Morrow DH: The effect of halothane on
ventricular automaticity. Anesthesiology 36:107,
1972.
522. Ivankovich AD, Miletich DJ, Grossman RK, et al:
The effect of enflurane, isoflurane, fluroxene, met
hoxyflurane and diethyl ether on ouabain tolerance
in the dog. Anesth Analg 55:360, 1976.
523. Ali N, Dais K, Banks T, Sheikh M: Titrated electrical
cardioversion in patients on digoxin. Clin Cardiol
5:417, 1982.
524. Adverse systemic effects from ophthalmic drugs.
Med Lett Drugs Ther 24:53, 1982.
525. The Medical Letter Handbook of Adverse Drug
Interactions, 2003.
526. Feely J, Wilkinson GR, McAllister CB, et al: Increa-
sed toxicity and reduced clearance of lidocaine by
cimetidine. Ann Intern Med 96:592, 1982.
914
Control de la anestesia
III